Nexalin Technology, Inc. And Wider Come Limited Announce Joint Venture Agreement To Advance Commercialization Of Nexalin's tACS Devices In The Asia Pacific Region
Portfolio Pulse from Happy Mohamed
Nexalin Technology (NASDAQ:NXL) has announced a joint venture with Wider Come Limited to advance the commercialization of Nexalin's second generation transcranial Alternating Current Stimulation (tACS) devices in the Asia Pacific region. Wider will fund and conduct four clinical trials evaluating the treatment of patients with insomnia, depression, and other indications using Nexalin's Gen-2 devices.
June 01, 2023 | 12:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Nexalin Technology's joint venture with Wider Come Limited will advance the commercialization of its tACS devices in the Asia Pacific region, potentially increasing its market share and revenues.
The joint venture between Nexalin Technology and Wider Come Limited will help expand the commercialization of Nexalin's tACS devices in the Asia Pacific region. This expansion can lead to increased market share and revenues for Nexalin. Additionally, Wider's funding of four clinical trials will provide valuable data to support clinical and commercial activities in North America and elsewhere, further benefiting Nexalin.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100